BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33907931)

  • 21. Multimodal molecular analysis of an atypical small cell carcinoma of the ovary, hypercalcemic type.
    David MP; Venkatramani R; Lopez-Terrada DH; Roy A; Patil N; Fisher KE
    Cold Spring Harb Mol Case Stud; 2018 Oct; 4(5):. PubMed ID: 30275002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Driver Mutations in Rare Cancers: The Role of SMARCA4 in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT).
    Lang JD; Hendricks WPD
    Methods Mol Biol; 2018; 1706():367-379. PubMed ID: 29423809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian small cell carcinoma in one of a pair of monozygous twins.
    Fahiminiya S; Sabbaghian N; Albrecht S; Nadaf J; Callegaro-Filho D; Foulkes WD
    Fam Cancer; 2019 Apr; 18(2):161-163. PubMed ID: 30284660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): Comprehensive management of a newly diagnosed young adult.
    Pressey JG; Dandoy CE; Pater LE; Sroga Rios J; Sisson R; Dasgupta R; Szabo S
    Gynecol Oncol; 2020 Sep; 158(3):538-546. PubMed ID: 32654763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small Cell Carcinoma of Ovary, Hypercalcemic Type: A Rare Case Report.
    Coşkun Ç; Kurucu N; Usubutun A; Soyer T; Ozcan HN; Çelik Ertaş NB; Kutluk T
    J Pediatr Adolesc Gynecol; 2023 Apr; 36(2):112-115. PubMed ID: 36243275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type.
    Jelinic P; Schlappe BA; Conlon N; Tseng J; Olvera N; Dao F; Mueller JJ; Hussein Y; Soslow RA; Levine DA
    Mod Pathol; 2016 Jan; 29(1):60-6. PubMed ID: 26564006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics: SMARCA4 mutated in SCCOHT.
    Errico A
    Nat Rev Clin Oncol; 2014 Jun; 11(6):302. PubMed ID: 24732945
    [No Abstract]   [Full Text] [Related]  

  • 28. Loss of SMARCA4 Expression Is Both Sensitive and Specific for the Diagnosis of Small Cell Carcinoma of Ovary, Hypercalcemic Type.
    Conlon N; Silva A; Guerra E; Jelinic P; Schlappe BA; Olvera N; Mueller JJ; Tornos C; Jungbluth AA; Young RH; Oliva E; Levine D; Soslow RA
    Am J Surg Pathol; 2016 Mar; 40(3):395-403. PubMed ID: 26645725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2:
    Chan-Penebre E; Armstrong K; Drew A; Grassian AR; Feldman I; Knutson SK; Kuplast-Barr K; Roche M; Campbell J; Ho P; Copeland RA; Chesworth R; Smith JJ; Keilhack H; Ribich SA
    Mol Cancer Ther; 2017 May; 16(5):850-860. PubMed ID: 28292935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SMARCA4-deficient undifferentiated carcinoma of the ovary (small cell carcinoma, hypercalcemic type): clinicopathologic and immunohistochemical study of 3 cases.
    Agaimy A; Thiel F; Hartmann A; Fukunaga M
    Ann Diagn Pathol; 2015 Oct; 19(5):283-7. PubMed ID: 26123103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SMARCA4-Deficient Carcinoma of Uterine Cervix Resembling SCCOHT-Case Report.
    Sirák I; Laco J; Vošmiková H; Mell LK; Herrera FG; Šenkeříková M; Vošmik M
    Pathol Oncol Res; 2021; 27():1610003. PubMed ID: 34970085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Ovarian Rhabdoid Tumor) with
    Simões MFE; da Costa AABA; Silva TN; Fernandes L; Bovolim G; Torrezan GT; Carraro DM; Baiocchi G; Menezes ANO; Santana Dos Santos E; De Brot L
    Curr Oncol; 2022 Jan; 29(2):411-422. PubMed ID: 35200537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No small surprise - small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour.
    Foulkes WD; Clarke BA; Hasselblatt M; Majewski J; Albrecht S; McCluggage WG
    J Pathol; 2014 Jul; 233(3):209-14. PubMed ID: 24752781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma.
    Kolin DL; Dong F; Baltay M; Lindeman N; MacConaill L; Nucci MR; Crum CP; Howitt BE
    Mod Pathol; 2018 Sep; 31(9):1442-1456. PubMed ID: 29700418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer.
    Herold N; Schmolling J; Ernst C; Ataseven B; Blümcke B; Schömig-Markiefka B; Heikaus S; Göhring UJ; Engel C; Lampe B; Rhiem K; Harter P; Hauke J; Schmutzler RK; Hahnen E
    Cancer Med; 2023 Jul; 12(14):15256-15260. PubMed ID: 37345881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Li-Fraumeni Syndrome With Small Cell Carcinoma of the Ovary, Hypercalcemic Type and Concurrent Pleomorphic Liposarcoma of the Cervix.
    Tandon B; Hagemann IS; Maluf HM; Pfeifer JD; Al-Kateb H
    Int J Gynecol Pathol; 2017 Nov; 36(6):593-599. PubMed ID: 28177947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines.
    Karnezis AN; Chen SY; Chow C; Yang W; Hendricks WPD; Ramos P; Briones N; Mes-Masson AM; Bosse T; Gilks CB; Trent JM; Weissman B; Huntsman DG; Wang Y
    Gynecol Oncol; 2021 Feb; 160(2):568-578. PubMed ID: 33328126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small Cell Carcinoma of the Ovary, Hypercalcemic Type, in a 12-Month-Old Girl.
    Atwi D; Quinton MR; Kiser RM; Pokala HR; Rooms LM; Yu Z
    Pediatr Dev Pathol; 2021; 24(5):493-497. PubMed ID: 34047234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type.
    Wang Y; Chen SY; Colborne S; Lambert G; Shin CY; Santos ND; Orlando KA; Lang JD; Hendricks WPD; Bally MB; Karnezis AN; Hass R; Underhill TM; Morin GB; Trent JM; Weissman BE; Huntsman DG
    Mol Cancer Ther; 2018 Dec; 17(12):2767-2779. PubMed ID: 30232145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type.
    Andrianteranagna M; Cyrta J; Masliah-Planchon J; Nemes K; Corsia A; Leruste A; Holdhof D; Kordes U; Orbach D; Corradini N; Entz-Werle N; Pierron G; Castex MP; Brouchet A; Weingertner N; Ranchère D; Fréneaux P; Delattre O; Bush J; Leary A; Frühwald MC; Schüller U; Servant N; Bourdeaut F
    J Pathol; 2021 Sep; 255(1):1-15. PubMed ID: 33999421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.